Cargando…
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Vaccine protection from symptomatic SARS-CoV-2 infection has been shown to be strongly correlated with neutralising antibody titres; however, this has not yet been demonstrated for severe COVID-19. To explore whether this relationship also holds for severe COVID-19, we performed a systematic search...
Autores principales: | Cromer, Deborah, Steain, Megan, Reynaldi, Arnold, Schlub, Timothy E., Khan, Shanchita R., Sasson, Sarah C., Kent, Stephen J., Khoury, David S., Davenport, Miles P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036966/ https://www.ncbi.nlm.nih.gov/pubmed/36964146 http://dx.doi.org/10.1038/s41467-023-37176-7 |
Ejemplares similares
-
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022) -
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023) -
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021) -
Monoclonal antibody levels and protection from COVID-19
por: Stadler, Eva, et al.
Publicado: (2023) -
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
por: Kent, Stephen J., et al.
Publicado: (2022)